ECRI issues IV fluid shortage guidance: 5 things to know

Amid the IV fluid shortage caused by the temporary closure of Baxter’s North Cove, N.C., plant due to Hurricane Helene, ECRI has issued guidance to healthcare providers regarding practices to avoid and adopt. 

Advertisement

Here are five things to know regarding the organization’s guidance, issued in an Oct. 16 news release:

  1. Avoid preparing smaller doses from fluid bags outside sterile compounding areas, especially without using IV workflow management systems. 
  2. Storing concentrated sodium chloride vials or large bags of sterile water outside the pharmacy can lead to contamination and other risks. 
  3. Ensure that practitioners understand how to administer medications correctly, particularly when switching from infusion to IV push methods, to prevent rate confusion. 
  4. New products from alternative manufacturers may have similar packaging, increasing the risk of medication errors. 
  5. Do not bypass barcode medication administration protocols due to unscannable barcodes, as this can lead to critical errors. 

As the FDA works to temporarily import IV products, ECRI stressed the importance of reporting critical errors and sharing lessons learned to enhance patient safety, according to the release. 

Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit

Advertisement

Next Up in Supply Chain

Advertisement

Comments are closed.